ABSTRACT OBJECTIVES This study aimed to investigate the role of atrial natriuretic peptide (ANP) levels to predict left atrial (LA) reverse remodeling in atrial fibrillation (AF) patients.
remodeling leads to subsequent improvement in the LA (9) and left ventricular (LV) function (10) , prediction of reverse remodeling is of crucial importance.
Atrial natriuretic peptide (ANP) is a hormone released from atrial myocytes in response to volume or pressure overload (11) .
Although elevated plasma ANP levels are frequently observed in AF patients (12) (13) (14) , data indicate that ANP levels are low in patients with advanced atrial fibrosis (15, 16) .
Thus, we hypothesized that elevated ANP levels in AF patients partially reflect the viability of LA myocytes, which may result in a considerable decrease in LA volume after RFCA. This study aimed to investigate the role of ANP levels to predict LA reverse remodeling in patients who underwent RFCA for AF.
METHODS STUDY POPULATION.
The study population consisted of 104 consecutive patients who had paroxysmal (n ¼ 65) and persistent AF (n ¼ 39) refractory to antiarrhythmic treatment and who were referred to undergo RFCA first. The exclusion criteria were: 1) history of myocardial infarction; 2) moderate or severe valvular disease; 3) dilated or hypertrophic cardiomyopathy; 4) thyroid dysfunction; and 5) renal insufficiency (serum creatinine level $1.5 mg/dl). AF was defined as paroxysmal when the arrhythmia selfterminated within 7 days and as persistent when the AF episode persisted for 7 days, or pharmacological or electrical cardioversion was required to terminate the arrhythmia (17) . Self-reported AF burden was evaluated on the basis of a modified arrhythmia frequency and severity scale, from 1 to 10 points for each frequency and duration of AF episodes (range 2 to 20) (18, 19) . All patients underwent multidetector computed tomography (MDCT) examination 7 AE 3 days before and 6 months after RFCA. Laboratory tests, including measurement of ANP, plasma B-type natriuretic peptide (BNP), and high-sensitivity C-reactive protein (hs-CRP) levels were performed before RFCA on the day of ablation and at 6-month intervals after RFCA. This study was approved by the institutional review board of Baba Memorial Hospital, and written informed consent was obtained from all patients.
MEASUREMENT OF ANP, BNP, AND hs-CRP. Blood samples were collected from the antecubital vein after patients rested in the supine position for $30 min.
All samples were drawn in the morning before taking medication. Samples were collected in tubes containing 1.25 mg/ml of ethylenediaminetetraacetic acid and a protease inhibitor, aprotinin 500 KIU/ml (for measurement of ANP and BNP). The plasma was separated by centrifugation (at 2,500 rpm) for 10 min at 20
C and stored at À70 C until measurement. (Iopamidol 370, Hikari Co., Tokyo, Japan) was injected intravenously at a flow rate of 4.0 to 5.5 ml/s, followed by 40 ml of saline solution at a rate of 5 ml/s.
Serum
The raw data were reconstructed using algorithms optimized for ECG-gated multislice spiral reconstruction. Images were transferred to a commercially available workstation, SYNAPSE VINCENT (Fujifilm Medical Co., Tokyo, Japan). All MDCT analyses were performed by experienced physicians blinded to other information. The following parameters were assessed.
1. The LA volume was measured using Simpson's rule at end-systole. Pulmonary veins (PVs) and the LA appendage were carefully excluded.
2. Manual planimetry of the endocardial and epicardial LV borders (to define the LV myocardial area) was performed at end-diastole, on short-and longaxis images. The LV volume was calculated using the modified Simpson's method, in which the sum of the cross-sectional areas was multiplied by the sum of slice thicknesses. The LV papillary muscles were excluded from the mass measurement. The LV mass was calculated using the following formula: 1.05 g/ml Â LV volume.
The LA volume and LV mass were indexed for body surface area. Nakanishi et al.
Atrial Natriuretic Peptide and Atrial Fibrillation Holter monitor recording after a 2-month blanking period from the RFCA procedure.
To study the determinants of LA reverse remodeling after catheter ablation, the study population was divided into 2 groups according to the extent of decrease in the LA volume index during follow-up.
Responders were defined as patients who exhibited a $15% decrease in the LA volume index at 6 months after RFCA (8, 20) . Nonresponders were defined as patients who exhibited a <15% decrease or an increase in the LA volume index on MDCT 6 months after RFCA. patients (72%) remained in sinus rhythm, whereas 29 patients (28%) had a recurrence of AF. Pre-procedural serum ANP and BNP levels were significantly higher in the responders than in the nonresponders ( Table 1) . There was a significant correlation between the percentage decrease in the LA volume index and the pre-procedural serum log ANP ( Figure 1A ) and log BNP levels ( Figure 1B) , whereas there was no correlation between the percentage decrease in the LA volume index and the log hs-CRP level ( Figure 1C) . The serum log ANP, log BNP, and log hs-CRP levels showed different trends during follow-up according to the presence of LA reverse remodeling. During the 6-month follow-up, the serum log ANP, log BNP, and log hs-CRP levels decreased significantly in the responders, whereas no changes in these levels were observed in the nonresponders (Figures 2A to 2C 
DISCUSSION
In this study, 47% of the patients exhibited LA reverse remodeling after RFCA for AF. In these responders, the serum ANP, BNP, and hs-CRP levels decreased significantly from baseline to follow-up. In contrast, no changes in these laboratory Nakanishi et al.
Atrial Natriuretic Peptide and Atrial Fibrillation Sacher et al. also reported a decrease in the serum ANP level from 73 to 27 pg/ml at 3 months after RFCA in 43 AF patients (14) . In contrast, perpetuation of AF induced myocyte loss and subsequent atrial interstitial fibrosis, resulting in insufficient ANP secretion (15) . A previous histopathological study demonstrated an inverse correlation between the serum ANP level and LA collagen volume in AF patients (16) . The present study showed that the pre-procedural ANP level was associated with the extent of reverse structural remodeling independent of the AF type, LA volume index, and maintenance of sinus rhythm after RFCA.
These observations suggest that reverse structural remodeling is more likely to occur in the elastic LA with preserved LA myocytes and less fibrosis, which can secrete ANP into systemic circulation.
STUDY LIMITATIONS. First, this was a single-center study with a relatively small number of patients.
Second, mid-regional pro-ANP was recently developed, and it has been reported to be more stable than mature ANP (27) . Mid-regional pro-ANP has so far been shown to offer comparable diagnostic and prognostic performance in patients with heart failure (28), acute coronary syndrome (29) , and stroke (30) .
However, in this study, we measured serum mature ANP levels and did not evaluate mid-regional pro- Nakanishi et al.
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